CN102958515A - 非索非那定微胶囊及含有非索非那定微胶囊的组合物 - Google Patents
非索非那定微胶囊及含有非索非那定微胶囊的组合物 Download PDFInfo
- Publication number
- CN102958515A CN102958515A CN2010800617656A CN201080061765A CN102958515A CN 102958515 A CN102958515 A CN 102958515A CN 2010800617656 A CN2010800617656 A CN 2010800617656A CN 201080061765 A CN201080061765 A CN 201080061765A CN 102958515 A CN102958515 A CN 102958515A
- Authority
- CN
- China
- Prior art keywords
- microcapsule
- fexofenadine
- pharmaceutical composition
- insoluble polymer
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Description
成分 |
非索非那定, |
乙基纤维素, |
埃波纶低分子量聚乙烯1, |
环己烷2 |
步骤 |
用相分离凝聚 |
洗涤 |
过滤 |
干燥 |
筛分 |
批次 | 包衣重量(%) |
样品1 | 10 |
样品2 | 13 |
样品3 | 15 |
样品4 | 15 |
样品5 | 17 |
样品6 | 20 |
样品7 | 20 |
样品 | 乙基纤维素 | 润湿处理 | 环己烷残留量 |
样品12 | 17% | 否 | 21ppm |
样品12--D | 17% | 是 | 15ppm |
样品11 | 15% | 否 | 26ppm |
样品11-D | 15% | 是 | 17ppm |
样品6-D2 | 20% | 是 | 13ppm |
样品29 | 25% | 否 | 27ppm |
样品29--D | 25% | 是 | 36ppm |
>355μm | 在355与125μm之间 | <125μm |
1.0 | 4.0 | 95.0 |
1.0 | 6.0 | 93.0 |
0.0 | 2.0 | 98.0 |
0.0 | 1.0 | 99.0 |
0.0 | 2.0 | 98.0 |
1.0 | 2.0 | 97.0 |
Claims (54)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810094768.8A CN108159019A (zh) | 2009-12-02 | 2010-12-01 | 非索非那定微胶囊及含有非索非那定微胶囊的组合物 |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26582309P | 2009-12-02 | 2009-12-02 | |
US61/265,823 | 2009-12-02 | ||
US35457510P | 2010-06-14 | 2010-06-14 | |
US61/354,575 | 2010-06-14 | ||
PCT/IB2010/003196 WO2011067667A2 (en) | 2009-12-02 | 2010-12-01 | Fexofenadine microcapsules and compositions containing them |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810094768.8A Division CN108159019A (zh) | 2009-12-02 | 2010-12-01 | 非索非那定微胶囊及含有非索非那定微胶囊的组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102958515A true CN102958515A (zh) | 2013-03-06 |
Family
ID=43989749
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010800617656A Pending CN102958515A (zh) | 2009-12-02 | 2010-12-01 | 非索非那定微胶囊及含有非索非那定微胶囊的组合物 |
CN201810094768.8A Pending CN108159019A (zh) | 2009-12-02 | 2010-12-01 | 非索非那定微胶囊及含有非索非那定微胶囊的组合物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810094768.8A Pending CN108159019A (zh) | 2009-12-02 | 2010-12-01 | 非索非那定微胶囊及含有非索非那定微胶囊的组合物 |
Country Status (21)
Country | Link |
---|---|
US (6) | US8580313B2 (zh) |
EP (1) | EP2506836B1 (zh) |
JP (3) | JP5309262B2 (zh) |
KR (1) | KR101765357B1 (zh) |
CN (2) | CN102958515A (zh) |
AR (1) | AR079248A1 (zh) |
AU (1) | AU2010325746B2 (zh) |
CA (1) | CA2782285A1 (zh) |
CL (1) | CL2012001451A1 (zh) |
CO (1) | CO6541583A2 (zh) |
ES (1) | ES2668203T3 (zh) |
IL (1) | IL220085A (zh) |
MX (1) | MX2012006240A (zh) |
NZ (1) | NZ600256A (zh) |
RU (1) | RU2563623C2 (zh) |
SA (1) | SA110310896B1 (zh) |
SG (1) | SG10201407965XA (zh) |
TW (1) | TWI471146B (zh) |
UY (1) | UY33076A (zh) |
WO (1) | WO2011067667A2 (zh) |
ZA (1) | ZA201203983B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113197867A (zh) * | 2021-05-07 | 2021-08-03 | 济川(上海)医学科技有限公司 | 一种非索非那定掩味颗粒,包含其的掩味组合物和掩味制剂,以及制备方法和用途 |
CN114343230A (zh) * | 2022-02-10 | 2022-04-15 | 湖北中烟工业有限责任公司 | 一种薄片添加剂、其制备方法及含有该薄片添加剂的烟草薄片 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ600256A (en) * | 2009-12-02 | 2014-05-30 | Aptalis Pharma Ltd | Fexofenadine microcapsules and compositions containing them |
JP6176840B2 (ja) * | 2012-06-29 | 2017-08-09 | 高田製薬株式会社 | フェキソフェナジン顆粒製剤及びその製造方法 |
EP2976069B1 (en) * | 2013-03-22 | 2020-05-06 | Adare Pharmaceuticals S.R.L. | Piperaquine microcapsules and compositions containing them |
GB201308933D0 (en) * | 2013-05-17 | 2013-07-03 | Diurnal Ltd | Paediatric composition |
CN105358138A (zh) * | 2013-07-03 | 2016-02-24 | R.P.谢勒技术有限公司 | 包含非索非那定的胶囊制剂 |
EP3110403B1 (en) * | 2014-02-25 | 2019-11-06 | Orbis Biosciences, Inc. | Taste masking drug formulations |
AU2015306683B2 (en) | 2014-08-25 | 2021-11-25 | Societe Des Produits Nestle S.A. | Egg protein formulations and methods of manufacture thereof |
US11612564B2 (en) | 2018-04-21 | 2023-03-28 | Quest Products, Llc | Bilayer adhering lozenge effective to mask undesirable flavor |
WO2022175829A1 (en) * | 2021-02-17 | 2022-08-25 | Cellix Bio Private Limited | Topical formulations and compositions |
CN113522186A (zh) * | 2021-07-19 | 2021-10-22 | 上海应用技术大学 | 一种香精微胶囊及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1219291A1 (en) * | 2000-12-21 | 2002-07-03 | McNeill-PPC, Inc. | Texture masked particles containing an active ingredient |
WO2003041683A2 (en) * | 2001-11-16 | 2003-05-22 | Ethypharm | Orodispersible tablets containing fexofenadine |
EP1491184A1 (en) * | 2003-06-27 | 2004-12-29 | McNEIL-PPC, INC. | Soft tablet containing high molecular weight cellulosics |
US20070048373A1 (en) * | 2005-08-30 | 2007-03-01 | Cima Labs Inc. | Dried milled granulate and methods |
Family Cites Families (271)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB906422A (en) | 1958-05-02 | 1962-09-19 | Wellcome Found | Improvements in and relating to prolonged acting pharmaceutical preparations |
JPS4111273Y1 (zh) | 1964-04-01 | 1966-05-25 | ||
US3558768A (en) | 1969-12-19 | 1971-01-26 | Sterling Drug Inc | Sustained release pharmaceutical compositions |
DE2246013A1 (de) | 1972-09-20 | 1974-03-28 | Boehringer Mannheim Gmbh | Verfahren zur herstellung von poroesen tabletten |
JPS4969819U (zh) | 1972-10-02 | 1974-06-18 | ||
US4078051A (en) | 1973-02-05 | 1978-03-07 | L'oreal | Cross-linked starch coated antiperspirant derivative of aluminum, process for its preparation and antiperspirant composition containing same |
IE45770B1 (en) | 1976-10-06 | 1982-11-17 | Wyeth John & Brother Ltd | Pharmaceutical dosage forms |
GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
GB1561204A (en) | 1977-06-01 | 1980-02-13 | Ici Ltd | Sustained release pharmaceutical composition |
CA1097233A (en) | 1977-07-20 | 1981-03-10 | George K. E. Gregory | Packages |
JPS55129224A (en) | 1979-03-27 | 1980-10-06 | Toyo Jozo Co Ltd | Fine granules having improved taste |
JPS5614098A (en) | 1979-07-13 | 1981-02-10 | Takeda Chem Ind Ltd | Externally lubricating tablet making machine |
US4248857A (en) | 1979-08-09 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4292017A (en) | 1980-07-09 | 1981-09-29 | Doepel Wallace A | Apparatus for compressing tablets |
US4389330A (en) | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
CA1181430A (en) | 1980-11-14 | 1985-01-22 | Bennie J. Foster | (-) - n-methyl-3-(2-methylphenox)-3-phenylpropylamine, antidepressant |
US4587118A (en) | 1981-07-15 | 1986-05-06 | Key Pharmaceuticals, Inc. | Dry sustained release theophylline oral formulation |
US4369172A (en) | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4389393A (en) | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4556678A (en) | 1982-06-24 | 1985-12-03 | Key Pharmaceuticals, Inc. | Sustained release propranolol tablet |
JPS5916821A (ja) | 1982-07-16 | 1984-01-28 | Tanabe Seiyaku Co Ltd | 非凝集性マイクロカプセルの製法 |
US4698101A (en) | 1982-08-30 | 1987-10-06 | Suomen Sokeri Oy (Finnish Sugar Company Ltd.) | Binder-diluent composition and method |
PH18946A (en) | 1983-04-21 | 1985-11-14 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
US4851229A (en) | 1983-12-01 | 1989-07-25 | Alza Corporation | Composition comprising a therapeutic agent and a modulating agent |
US4708867A (en) | 1983-12-19 | 1987-11-24 | Key Pharmaceuticals, Inc. | Minipellets |
US4894240A (en) | 1983-12-22 | 1990-01-16 | Elan Corporation Plc | Controlled absorption diltiazem formulation for once-daily administration |
US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
SE457505B (sv) | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
DK62184D0 (da) | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
AU571312B2 (en) | 1984-02-10 | 1988-04-14 | Nycomed Danmark A/S | Diffusion coated multiple-units dosage form |
JPS6115830A (ja) | 1984-06-28 | 1986-01-23 | ザ プロクタ− アンド ガンブル カンパニ− | 制酸剤組成物およびその製造方法 |
JPS6150978A (ja) | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
FR2571046B1 (fr) | 1984-10-03 | 1987-10-16 | Roquette Freres | Procede de preparation de mannitol granulaire directement compressible |
US4670459A (en) | 1984-10-03 | 1987-06-02 | Merrell Dow Pharmaceuticals Inc. | Method of alleviating withdrawal symptoms |
FR2571045B1 (fr) | 1984-10-03 | 1987-12-11 | Roquette Freres | Mannitol granulaire directement compressible et son procede de fabrication |
JPH0653658B2 (ja) | 1984-12-17 | 1994-07-20 | 中外製薬株式会社 | 安定な錠剤の製造法 |
DE3505433A1 (de) | 1985-02-16 | 1986-08-21 | Basf Ag, 6700 Ludwigshafen | Direkttablettierhilfsmittel |
US4728512A (en) | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
GB8518301D0 (en) | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
JPS6250445A (ja) | 1985-08-29 | 1987-03-05 | Japanese National Railways<Jnr> | Fe基焼結材料製電気車のパンタグラフすり板材 |
SE455836B (sv) | 1985-10-11 | 1988-08-15 | Haessle Ab | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
GB8530365D0 (en) | 1985-12-10 | 1986-01-22 | Univ Bath | Manufacture of moulded products |
DE3684446D1 (de) | 1985-12-28 | 1992-04-23 | Sumitomo Pharma | Arzneimittel mit verzoegerter stossweiser freisetzung. |
ZA87279B (en) | 1986-01-17 | 1987-09-30 | Chugai Pharmaceutical Co Ltd | Method for production of stable nicorandil preparation |
US5433959A (en) | 1986-02-13 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
CA1327010C (en) | 1986-02-13 | 1994-02-15 | Tadashi Makino | Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production |
SE457326B (sv) | 1986-02-14 | 1988-12-19 | Lejus Medical Ab | Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa |
JP2512302B2 (ja) | 1986-03-19 | 1996-07-03 | 中外製薬株式会社 | ニコランジル安定化製剤の製造方法 |
AU591248B2 (en) | 1986-03-27 | 1989-11-30 | Kinaform Technology, Inc. | Sustained-release pharaceutical preparation |
US5238686A (en) | 1986-03-27 | 1993-08-24 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
JPH0774153B2 (ja) | 1986-04-14 | 1995-08-09 | 三共株式会社 | ロキソプロフェン・ナトリウム含有製剤 |
US4786508A (en) | 1986-05-30 | 1988-11-22 | Warner-Lambert Company | Coated dosage forms |
IE58401B1 (en) | 1986-06-20 | 1993-09-08 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
US4757090A (en) | 1986-07-14 | 1988-07-12 | Mallinckrodt, Inc. | Direct tableting acetaminophen compositions |
US4743248A (en) | 1986-08-11 | 1988-05-10 | Alza Corporation | Dosage form for delivering acid sensitive beneficial agent |
IT1200217B (it) | 1986-09-30 | 1989-01-05 | Valducci Roberto | Membrana per uso farmaceutico ed industriale |
US4760093A (en) | 1986-10-21 | 1988-07-26 | American Home Products Corporation (Del.) | Spray dried acetaminophen |
US4752470A (en) | 1986-11-24 | 1988-06-21 | Mehta Atul M | Controlled release indomethacin |
US4800087A (en) | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
GB8628359D0 (en) | 1986-11-27 | 1986-12-31 | Zyma Sa | Galenical formulation |
KR910002669B1 (ko) | 1986-12-25 | 1991-05-03 | 데이산세이야꾸 가부시끼가이샤 | 서방성 과립 및 그를 함유하는 지속성 복합과립 |
JPS63162619A (ja) | 1986-12-25 | 1988-07-06 | Teisan Seiyaku Kk | 遅溶性顆粒及びそれを用いた持続性複合顆粒 |
US5026560A (en) | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
US4968508A (en) | 1987-02-27 | 1990-11-06 | Eli Lilly And Company | Sustained release matrix |
US4874613A (en) | 1987-03-06 | 1989-10-17 | Baker Cummins Pharmaceuticals, Inc. | Taste concealing pharmaceutical dosage unit |
GB8710965D0 (en) | 1987-05-08 | 1987-06-10 | Smith Kline French Lab | Pharmaceutical compositions |
KR960011236B1 (ko) | 1987-05-08 | 1996-08-21 | 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 | 제약학적 조성물 및 고체 제형 |
DE3720757A1 (de) | 1987-06-24 | 1989-01-05 | Bayer Ag | Dhp-manteltablette |
US4915949A (en) | 1987-07-13 | 1990-04-10 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
US4824675A (en) | 1987-07-13 | 1989-04-25 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
US4851226A (en) | 1987-11-16 | 1989-07-25 | Mcneil Consumer Products Company | Chewable medicament tablet containing means for taste masking |
US4971805A (en) | 1987-12-23 | 1990-11-20 | Teysan Pharmaceuticals Co., Ltd. | Slow-releasing granules and long acting mixed granules comprising the same |
US5211957A (en) | 1988-03-25 | 1993-05-18 | Ciba-Geigy Corporation | Solid rapidly disintegrating dosage form |
EP0349103B1 (en) | 1988-05-04 | 1992-11-25 | Smith Kline & French Laboratories Limited | Chewable tablet |
US4938968A (en) | 1988-07-26 | 1990-07-03 | Norjec Development Associates, Inc. | Controlled release indomethacin |
IL91398A (en) | 1988-08-30 | 1994-05-30 | Pfizer | A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane |
US5612059A (en) | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
US5256699A (en) | 1988-10-18 | 1993-10-26 | Ciba-Geify Corporation | Dispersible tablet formulation of diclofenac acid free base |
GB8824392D0 (en) | 1988-10-18 | 1988-11-23 | Ciba Geigy Ag | Dispersible formulation |
HU200926B (en) | 1988-10-28 | 1990-09-28 | Egyt Gyogyszervegyeszeti Gyar | Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules |
US5112616A (en) | 1988-11-30 | 1992-05-12 | Schering Corporation | Fast dissolving buccal tablet |
US5073374A (en) | 1988-11-30 | 1991-12-17 | Schering Corporation | Fast dissolving buccal tablet |
US5104648A (en) | 1989-02-02 | 1992-04-14 | Mallinckrodt Specialty Chemicals Company | High ibuprofen content granulations |
DE69014141T2 (de) | 1989-02-10 | 1995-05-24 | Takeda Chemical Industries Ltd | Verwendung von Benzimidazol-Derivaten als antibakterielle Mittel. |
EP0386440B1 (de) | 1989-02-11 | 1992-08-05 | Bayer Ag | Arzneimittel mit kontrollierter Wirkstoffabgabe |
US5026559A (en) | 1989-04-03 | 1991-06-25 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
US4983401A (en) | 1989-05-22 | 1991-01-08 | Kinaform Technology, Inc. | Sustained release pharmaceutical preparations having pH controlled membrane coatings |
US5084278A (en) | 1989-06-02 | 1992-01-28 | Nortec Development Associates, Inc. | Taste-masked pharmaceutical compositions |
US4946684A (en) | 1989-06-20 | 1990-08-07 | American Home Products Corporation | Fast dissolving dosage forms |
US5082669A (en) | 1989-07-20 | 1992-01-21 | Dainippon Pharmaceutical Co., Ltd. | Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked |
US5079018A (en) | 1989-08-14 | 1992-01-07 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
US5039540A (en) | 1989-08-14 | 1991-08-13 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
DK469989D0 (da) | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
US5013557A (en) | 1989-10-03 | 1991-05-07 | Warner-Lambert Company | Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same |
FR2655266B1 (fr) | 1989-12-05 | 1992-04-03 | Smith Kline French Lab | Compositions pharmaceutiques a base de cimetidine. |
IT1238078B (it) | 1990-01-31 | 1993-07-05 | Silvano Spinelli | Cis-platino complessi con ammine e sulfinilcarbossilati chelanti |
US5229131A (en) | 1990-02-05 | 1993-07-20 | University Of Michigan | Pulsatile drug delivery system |
JP2781442B2 (ja) | 1990-02-19 | 1998-07-30 | 旭化成工業株式会社 | 顆粒含有錠剤 |
IT1246382B (it) | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
IT1246383B (it) | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per il mascheramento del sapore di farmaci |
US5017381A (en) | 1990-05-02 | 1991-05-21 | Alza Corporation | Multi-unit pulsatile delivery system |
US5075114A (en) | 1990-05-23 | 1991-12-24 | Mcneil-Ppc, Inc. | Taste masking and sustained release coatings for pharmaceuticals |
JP2558396B2 (ja) | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
IE61651B1 (en) | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
ZA919510B (en) | 1990-12-05 | 1992-10-28 | Smithkline Beecham Corp | Pharmaceutical compositions |
US5286497A (en) | 1991-05-20 | 1994-02-15 | Carderm Capital L.P. | Diltiazem formulation |
EP0516345A1 (en) | 1991-05-28 | 1992-12-02 | Eli Lilly And Company | Use of nizatidine for the manufacture of a medicament for the treatment of reflux esophagitis |
CA2068402C (en) | 1991-06-14 | 1998-09-22 | Michael R. Hoy | Taste mask coatings for preparation of chewable pharmaceutical tablets |
GB9113487D0 (en) | 1991-06-21 | 1991-08-07 | Amersham Int Plc | Agents for hypoxic cells |
US5252337A (en) | 1991-06-25 | 1993-10-12 | Eurand America, Inc. | Controlled release calcium channel blocker microcapsules |
JP3586471B2 (ja) | 1991-06-25 | 2004-11-10 | 三菱ウェルファーマ株式会社 | トラセミド含有医薬組成物 |
US5464632C1 (en) | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
FR2679451B1 (fr) | 1991-07-22 | 1994-09-09 | Prographarm Laboratoires | Comprime multiparticulaire a delitement rapide. |
CA2079934C (en) | 1991-10-15 | 2002-09-03 | Edward J. Roche | Taste mask coatings for preparing chewable pharmaceutical tablets |
US5229135A (en) | 1991-11-22 | 1993-07-20 | Prographarm Laboratories | Sustained release diltiazem formulation |
US5681585A (en) | 1991-12-24 | 1997-10-28 | Euro-Celtique, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
WO1993012769A1 (en) | 1991-12-24 | 1993-07-08 | Yamanouchi Pharmaceutical Co., Ltd. | Intrabuccally disintegrating preparation and production thereof |
DE69216642T2 (de) | 1992-01-13 | 1997-05-07 | Pfizer | Verfahren zur herstellung von tabletten mit hoher festigkeit |
DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
ATE216577T1 (de) | 1992-01-29 | 2002-05-15 | Takeda Chemical Industries Ltd | Schnellösliche tablette und ihre herstellung |
WO1993015724A1 (en) | 1992-02-18 | 1993-08-19 | Nippon Shinyaku Co., Ltd. | Fast soluble tablet |
US5260068A (en) | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
JPH05310558A (ja) | 1992-05-07 | 1993-11-22 | Lion Corp | 固形製剤組成物 |
TW271400B (zh) | 1992-07-30 | 1996-03-01 | Pfizer | |
JPH0653658A (ja) | 1992-08-19 | 1994-02-25 | Cmk Corp | 多層プリント配線板 |
MX9306393A (es) | 1992-10-16 | 1994-04-29 | Glaxo Group Ltd | Composiciones de ranitidina substancialmente libres de sabor amargo, proceso para su preparacion y composiciones farmaceuticas que las contienen. |
GB9224855D0 (en) | 1992-11-27 | 1993-01-13 | Smithkline Beecham Plc | Pharmaceutical compositions |
US5260069A (en) | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
US5376384A (en) | 1992-12-23 | 1994-12-27 | Kinaform Technology, Inc. | Delayed, sustained-release pharmaceutical preparation |
JP2500747B2 (ja) | 1993-05-10 | 1996-05-29 | 日本電気株式会社 | 半導体記憶装置およびその製造方法 |
JP3319625B2 (ja) | 1993-05-12 | 2002-09-03 | ホーユー株式会社 | 速崩壊性生薬製剤 |
CA2128820A1 (en) | 1993-07-27 | 1995-01-28 | Walter G. Gowan, Jr. | Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof |
JP2936376B2 (ja) | 1993-09-03 | 1999-08-23 | 小林化工株式会社 | ニコランジル錠剤の製法 |
JP2681601B2 (ja) | 1993-11-01 | 1997-11-26 | 協和醗酵工業株式会社 | 外部滑沢式打錠機 |
US5500227A (en) | 1993-11-23 | 1996-03-19 | Euro-Celtique, S.A. | Immediate release tablet cores of insoluble drugs having sustained-release coating |
US5576014A (en) | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
DE4412117A1 (de) | 1994-04-08 | 1995-10-12 | Fette Wilhelm Gmbh | Verfahren und Vorrichtung zum Aufbringen von pulverförmigem Schmier- oder Trennmittel auf die Preßwerkzeuge in Tablettiermaschinen |
GB9407386D0 (en) | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
US5536507A (en) | 1994-06-24 | 1996-07-16 | Bristol-Myers Squibb Company | Colonic drug delivery system |
ES2082723B1 (es) | 1994-07-20 | 1996-10-01 | Lilly Sa | Formulacion farmaceutica de fluoxetina en forma dispersable. |
US5609883A (en) | 1994-09-16 | 1997-03-11 | Advanced Technology Pharmaceuticals Corporation | Compressed tablet transitory lubricant system |
US5543099A (en) * | 1994-09-29 | 1996-08-06 | Hallmark Pharmaceutical, Inc. | Process to manufacture micronized nifedipine granules for sustained release medicaments |
GB9421837D0 (en) | 1994-10-28 | 1994-12-14 | Scherer Corp R P | Process for preparing solid pharmaceutical dosage forms |
US6103263A (en) | 1994-11-17 | 2000-08-15 | Andrx Pharmaceuticals, Inc. | Delayed pulse release hydrogel matrix tablet |
EP0714663A3 (en) | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
US5834024A (en) | 1995-01-05 | 1998-11-10 | Fh Faulding & Co. Limited | Controlled absorption diltiazem pharmaceutical formulation |
US5658590A (en) | 1995-01-11 | 1997-08-19 | Eli Lilly And Company | Treatment of attention-deficit/hyperactivity disorder |
US5639475A (en) | 1995-02-03 | 1997-06-17 | Eurand America, Incorporated | Effervescent microcapsules |
US5567441A (en) | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
WO1997004752A1 (en) | 1995-07-26 | 1997-02-13 | Duramed Pharmaceuticals, Inc. | Pharmaceutical compositions of conjugated estrogens and methods for their use |
US5807577A (en) | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
US5837284A (en) | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
US5762961A (en) | 1996-02-09 | 1998-06-09 | Quadrant Holdings Cambridge Ltd. | Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof |
US20030064108A1 (en) | 1996-04-23 | 2003-04-03 | Stefan Lukas | Taste masked pharmaceutical compositions |
AU2931997A (en) | 1996-05-07 | 1997-11-26 | Merck & Co., Inc. | Treatment of mood disorders with a growth hormone secretagogue |
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
TW506836B (en) | 1996-06-14 | 2002-10-21 | Janssen Pharmaceutica Nv | Fast-dissolving galanthamine hydrobromide tablet |
DE69733476T2 (de) | 1996-06-14 | 2006-03-23 | Kyowa Hakko Kogyo Co., Ltd. | Im munde schnellzerfallende tablette |
JP3708291B2 (ja) | 1996-06-21 | 2005-10-19 | 協和醗酵工業株式会社 | 微量粉体吐出装置及びこの装置を用いた微量粉体噴霧方法 |
EP1007012A4 (en) | 1996-10-01 | 2006-01-18 | Cima Labs Inc | TASTE-MASKED MICRO-CAPSULE COMPOSITION AND MANUFACTURING PROCESS |
FR2757173A1 (fr) | 1996-12-17 | 1998-06-19 | Warner Lambert Co | Compositions polymeres d'origine non-animale pour la formation de films |
US5788987A (en) | 1997-01-29 | 1998-08-04 | Poli Industria Chimica Spa | Methods for treating early morning pathologies |
US5891474A (en) | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
US5837379A (en) | 1997-01-31 | 1998-11-17 | Andrx Pharmaceuticals, Inc. | Once daily pharmaceutical tablet having a unitary core |
US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
US6162463A (en) | 1997-05-01 | 2000-12-19 | Dov Pharmaceutical Inc | Extended release formulation of diltiazem hydrochloride |
IT1291362B1 (it) | 1997-05-13 | 1999-01-07 | Vectorpharma Int | Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi |
US5840329A (en) | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
US5976577A (en) | 1997-07-11 | 1999-11-02 | Rp Scherer Corporation | Process for preparing fast dispersing solid oral dosage form |
FR2766089B1 (fr) | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
ES2137862B1 (es) | 1997-07-31 | 2000-09-16 | Intexim S A | Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion. |
AR016827A1 (es) | 1997-08-22 | 2001-08-01 | Smithkline Beecham Corp | PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA |
EP1027036A2 (en) | 1997-10-03 | 2000-08-16 | ELAN CORPORATION, Plc | Taste masked formulations |
ATE284211T1 (de) | 1997-11-06 | 2004-12-15 | Lannacher Heilmittel | Orale retard-präparation enthaltend tramadol sowie verfahren zu ihrer herstellung |
US6096340A (en) | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6221402B1 (en) | 1997-11-20 | 2001-04-24 | Pfizer Inc. | Rapidly releasing and taste-masking pharmaceutical dosage form |
FR2771292B1 (fr) | 1997-11-21 | 2000-02-18 | Ethypharm Lab Prod Ethiques | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques |
JPH11169437A (ja) | 1997-12-03 | 1999-06-29 | Kyowa Hakko Kogyo Co Ltd | 錠剤の製造方法 |
HUP0100469A2 (hu) * | 1997-12-19 | 2001-08-28 | Smithkline Beecham Corporation | Eljárás harapással diszpergálható tabletták előállítására |
DE69901938T3 (de) | 1998-03-06 | 2012-08-02 | Aptalis Pharma S.R.L. | Schnell zerfallende tablette |
ES2237912T3 (es) | 1998-03-09 | 2005-08-01 | Cima Labs Inc. | Aparato de manipulado y envasado de comprimidos fragiles. |
US6465009B1 (en) | 1998-03-18 | 2002-10-15 | Yamanouchi Pharmaceutical Co., Ltd. | Water soluble polymer-based rapidly dissolving tablets and production processes thereof |
US6099859A (en) | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
US6350470B1 (en) | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
US6509034B1 (en) | 1998-04-09 | 2003-01-21 | Eurand International S.P.A. | Wettable microcapsules having hydrophobic polymer coated cores |
AU764325B2 (en) | 1998-04-10 | 2003-08-14 | Kyowa Hakko Kirin Co., Ltd. | Tablet manufacturing methods and tablet |
KR20010034770A (ko) | 1998-04-17 | 2001-04-25 | 우에하라 아끼라 | 멀티플 유닛 타입 서방성 정제 |
ATE348601T1 (de) | 1998-05-18 | 2007-01-15 | Takeda Pharmaceutical | Im munde zerfallende tablette enthaltend ein benzimidazole |
FR2778848B1 (fr) | 1998-05-20 | 2001-11-23 | Prographarm Lab | Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation |
US5968554A (en) | 1998-07-07 | 1999-10-19 | Cascade Development, Inc. A Subsidiary Of Cardinal Health, Inc. | Sustained release pharmaceutical preparation |
US6099865A (en) | 1998-07-08 | 2000-08-08 | Fmc Corporation | Croscarmellose taste masking |
US6365182B1 (en) | 1998-08-12 | 2002-04-02 | Cima Labs Inc. | Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet |
US6368625B1 (en) | 1998-08-12 | 2002-04-09 | Cima Labs Inc. | Orally disintegrable tablet forming a viscous slurry |
US6106862A (en) | 1998-08-13 | 2000-08-22 | Andrx Corporation | Once daily analgesic tablet |
US6602521B1 (en) | 1998-09-29 | 2003-08-05 | Impax Pharmaceuticals, Inc. | Multiplex drug delivery system suitable for oral administration |
US6531152B1 (en) | 1998-09-30 | 2003-03-11 | Dexcel Pharma Technologies Ltd. | Immediate release gastrointestinal drug delivery system |
JP4613275B2 (ja) | 1998-11-02 | 2011-01-12 | エラン ファーマ インターナショナル,リミティド | 多粒子改質放出組成物 |
US6296868B1 (en) | 1998-11-19 | 2001-10-02 | Advanced Technology Pharmaceuticals Corporation | Chewable tablets containing mannitol and aspartame |
US6740341B1 (en) | 1998-11-25 | 2004-05-25 | Cima Labs Inc. | Taste masking rapid release coating system |
WO2000033821A1 (en) | 1998-12-07 | 2000-06-15 | Bristol-Myers Squibb Company | Enteric coated pravastatin bead formulation |
US6039979A (en) | 1999-01-13 | 2000-03-21 | Laboratoires Prographarm | Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation |
JP2002535271A (ja) | 1999-01-21 | 2002-10-22 | エラン コーポレーシヨン ピーエルシー | 多粒子ビソプロロール製剤 |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
FR2790387B1 (fr) | 1999-03-01 | 2001-05-18 | Prographarm Laboratoires | Comprime orodispersible presentant une faible friabilite et son procede de preparation |
HUP0300535A2 (hu) | 1999-04-07 | 2003-07-28 | Pfizer Products Inc. | CYP2D6 inhibitorok alkalmazása kombinált terápiákban és ezeket tartalmazó gyógyszerkészítmények |
FR2795962B1 (fr) | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif |
US6284270B1 (en) | 1999-08-04 | 2001-09-04 | Drugtech Corporation | Means for creating a mass having structural integrity |
AU6715600A (en) | 1999-08-26 | 2001-03-19 | Elan Corporation, Plc | Pharmaceutical formulations |
DE19961897A1 (de) | 1999-12-20 | 2001-06-28 | Basf Ag | Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen |
US6420473B1 (en) | 2000-02-10 | 2002-07-16 | Bpsi Holdings, Inc. | Acrylic enteric coating compositions |
US6627223B2 (en) | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
AU4278301A (en) | 2000-03-27 | 2001-10-08 | Kyowa Hakko Kogyo Co. Ltd. | Easy-to-take granule |
EP1277730A4 (en) | 2000-03-28 | 2005-03-16 | HEMMER OF NEOVASCULARIZATION | |
ES2284643T3 (es) | 2000-04-20 | 2007-11-16 | Novartis Ag | Composicion de revestimiento enmascarante del sabor. |
US6551617B1 (en) | 2000-04-20 | 2003-04-22 | Bristol-Myers Squibb Company | Taste masking coating composition |
US6316029B1 (en) | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
US6368628B1 (en) | 2000-05-26 | 2002-04-09 | Pharma Pass Llc | Sustained release pharmaceutical composition free of food effect |
US6350471B1 (en) | 2000-05-31 | 2002-02-26 | Pharma Pass Llc | Tablet comprising a delayed release coating |
US6500457B1 (en) | 2000-08-14 | 2002-12-31 | Peirce Management, Llc | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
US6344215B1 (en) | 2000-10-27 | 2002-02-05 | Eurand America, Inc. | Methylphenidate modified release formulations |
US20020077348A1 (en) | 2000-11-21 | 2002-06-20 | Dean Herbert M. | Dosage unit for cardioprotection |
CA2430288C (en) | 2000-12-01 | 2009-03-10 | Kyowa Hakko Kogyo Co., Ltd. | A composition improved in the solubility or oral absorbability |
US6287599B1 (en) | 2000-12-20 | 2001-09-11 | Shire Laboratories, Inc. | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
JP2004520039A (ja) | 2001-01-22 | 2004-07-08 | カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ | 3−ヒドロキシ−3−フェニルプロパンニトリルの立体選択的調製 |
PL201766B1 (pl) | 2001-01-31 | 2009-05-29 | Roehm Gmbh | Wielocząsteczkowa postać leku zawierająca przynajmniej dwa typy granulek powlekanych w odmienny sposób oraz jej zastosowanie |
ES2325484T3 (es) | 2001-03-06 | 2009-09-07 | Kyowa Hakko Kirin Co., Ltd. | Comprimidos de desintegracion rapida en la cavidad oral. |
FR2823668B1 (fr) | 2001-04-20 | 2004-02-27 | Ethypharm Lab Prod Ethiques | Comprimes effervescents orodispersibles |
CA2447693A1 (en) | 2001-05-31 | 2002-12-05 | Cima Labs Inc. | Taste-masking of highly water-soluble drugs |
AR034517A1 (es) | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
CA2451914A1 (en) | 2001-08-08 | 2003-02-20 | John-Michael Sauer | Combination therapy for the treatment of neurological disorders |
JP2005509605A (ja) | 2001-09-28 | 2005-04-14 | マクニール−ピーピーシー・インコーポレイテッド | 可食性組成物と可食性外皮を含む剤形 |
US6500454B1 (en) | 2001-10-04 | 2002-12-31 | Eurand Pharmaceuticals Ltd. | Timed, sustained release systems for propranolol |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
FR2831820B1 (fr) | 2001-11-05 | 2004-08-20 | Ethypharm Sa | Comprime orodispersible presentant une grande homogeneite et son procede de preparation |
HUP0402323A3 (en) | 2001-11-21 | 2008-04-28 | Eisai R & D Man Co | Preparation compositions containing acid-unstable physiologically acitve compounds and process for producing the same |
CZ12993U1 (cs) | 2001-11-23 | 2003-02-10 | Glaxo Group Limited | Farmaceutický prostředek |
GB0129117D0 (en) | 2001-12-05 | 2002-01-23 | Glaxo Group Ltd | Pharmaceutical composition |
US6663888B2 (en) | 2001-12-14 | 2003-12-16 | Eurand Pharmaceuticals Ltd. | Pulsatile release histamine H2 antagonist dosage form |
US20050025824A1 (en) | 2001-12-14 | 2005-02-03 | Eurand Pharmaceuticals Ltd. | Pulsatile release histamine H2 antagonist dosage form |
AU2003209673B2 (en) | 2002-03-08 | 2007-10-18 | M/S. Ind-Swift Limited | Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof |
EP1492511B3 (fr) * | 2002-04-09 | 2012-05-02 | Flamel Technologies | Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s) |
WO2004004693A1 (en) * | 2002-07-05 | 2004-01-15 | Collgegium Pharmaceutical | Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
AU2002368090A1 (en) | 2002-07-17 | 2004-02-09 | Eurand Pharmaceuticals Ltd | Process for the preparation of pharmaceutical microcapsules with enhanced tastemasking and high dissolution rate |
AU2003261223A1 (en) | 2002-07-25 | 2004-02-16 | Pharmacia Corporation | Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former |
WO2004022037A1 (en) | 2002-09-04 | 2004-03-18 | Ranbaxy Laboratories Limited | Taste masked dosage forms and processes for their preparation |
US20040121010A1 (en) | 2002-10-25 | 2004-06-24 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
WO2004087111A1 (en) | 2003-04-04 | 2004-10-14 | Ranbaxy Laboratories Limited | Oral taste masked pharmaceutical compositions |
JP4111273B2 (ja) | 2003-06-25 | 2008-07-02 | 株式会社リコー | 画像復号装置、プログラム、記憶媒体及び画像復号方法 |
JP3881640B2 (ja) | 2003-08-08 | 2007-02-14 | 塩野義製薬株式会社 | ロラタジンを含むドライシロップ剤 |
US20050152974A1 (en) | 2003-12-31 | 2005-07-14 | Garth Boehm | Atomoxetine formulations |
EP1737433B1 (en) | 2004-04-12 | 2007-11-14 | Pfizer Products Incorporated | Taste-masked drugs in rupturing multiparticulates |
US8545881B2 (en) | 2004-04-19 | 2013-10-01 | Eurand Pharmaceuticals, Ltd. | Orally disintegrating tablets and methods of manufacture |
CA2560882A1 (en) * | 2004-04-26 | 2005-11-03 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of fexofenadine hydrochloride and processes for their preparation |
US20050261278A1 (en) * | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
US20060024361A1 (en) * | 2004-07-28 | 2006-02-02 | Isa Odidi | Disintegrant assisted controlled release technology |
KR100555571B1 (ko) | 2004-09-07 | 2006-03-03 | 삼성전자주식회사 | 반도체 장치의 송신기 |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
NZ589750A (en) | 2004-10-21 | 2012-07-27 | Aptalis Pharmatech Inc | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US20060105038A1 (en) | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
RU2009106681A (ru) * | 2006-07-28 | 2010-09-10 | Др.Редди`С Лабораторис Лтд. (In) | Гранулированные фармацевтические композиции |
TWI547282B (zh) * | 2007-07-02 | 2016-09-01 | 愛戴爾製藥股份有限公司 | 樂命達之口服分解錠劑組合物 |
BRPI0820997A2 (pt) | 2007-12-10 | 2014-12-23 | Eurand Inc | Comprimidos de desintegração oral compreendendo difenidramina. |
TW200938186A (en) | 2008-02-13 | 2009-09-16 | Eurand Inc | Orally disintegrating tablet compositions of ranitidine and methods of manufacture |
NZ600256A (en) | 2009-12-02 | 2014-05-30 | Aptalis Pharma Ltd | Fexofenadine microcapsules and compositions containing them |
JP6250445B2 (ja) | 2014-03-19 | 2017-12-20 | Ntn株式会社 | 電気自動車のスリップ制御装置 |
-
2010
- 2010-12-01 NZ NZ600256A patent/NZ600256A/en not_active IP Right Cessation
- 2010-12-01 TW TW99141768A patent/TWI471146B/zh not_active IP Right Cessation
- 2010-12-01 KR KR1020127016707A patent/KR101765357B1/ko not_active Application Discontinuation
- 2010-12-01 ES ES10807361.0T patent/ES2668203T3/es active Active
- 2010-12-01 JP JP2012533709A patent/JP5309262B2/ja active Active
- 2010-12-01 MX MX2012006240A patent/MX2012006240A/es active IP Right Grant
- 2010-12-01 RU RU2012124262/15A patent/RU2563623C2/ru not_active IP Right Cessation
- 2010-12-01 WO PCT/IB2010/003196 patent/WO2011067667A2/en active Application Filing
- 2010-12-01 CN CN2010800617656A patent/CN102958515A/zh active Pending
- 2010-12-01 SG SG10201407965XA patent/SG10201407965XA/en unknown
- 2010-12-01 EP EP10807361.0A patent/EP2506836B1/en active Active
- 2010-12-01 CA CA2782285A patent/CA2782285A1/en not_active Abandoned
- 2010-12-01 AU AU2010325746A patent/AU2010325746B2/en not_active Ceased
- 2010-12-01 CN CN201810094768.8A patent/CN108159019A/zh active Pending
- 2010-12-02 US US12/959,113 patent/US8580313B2/en active Active
- 2010-12-02 UY UY0001033076A patent/UY33076A/es not_active Application Discontinuation
- 2010-12-02 AR ARP100104459A patent/AR079248A1/es unknown
- 2010-12-04 SA SA110310896A patent/SA110310896B1/ar unknown
-
2012
- 2012-05-31 ZA ZA2012/03983A patent/ZA201203983B/en unknown
- 2012-05-31 IL IL220085A patent/IL220085A/en not_active IP Right Cessation
- 2012-06-01 CL CL2012001451A patent/CL2012001451A1/es unknown
- 2012-06-06 CO CO12095687A patent/CO6541583A2/es unknown
-
2013
- 2013-07-01 JP JP2013138080A patent/JP5519839B2/ja active Active
- 2013-10-09 US US14/049,818 patent/US9233105B2/en active Active
-
2014
- 2014-04-03 JP JP2014076950A patent/JP5732572B2/ja active Active
-
2015
- 2015-12-02 US US14/956,786 patent/US10166220B2/en active Active
-
2018
- 2018-11-09 US US16/185,810 patent/US10729682B2/en active Active
-
2020
- 2020-06-23 US US16/909,055 patent/US20200316042A1/en not_active Abandoned
-
2021
- 2021-01-21 US US17/154,078 patent/US20210137899A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1219291A1 (en) * | 2000-12-21 | 2002-07-03 | McNeill-PPC, Inc. | Texture masked particles containing an active ingredient |
WO2003041683A2 (en) * | 2001-11-16 | 2003-05-22 | Ethypharm | Orodispersible tablets containing fexofenadine |
CN1592622A (zh) * | 2001-11-16 | 2005-03-09 | 爱的发 | 含有fexofenadine的口溶性片剂 |
EP1491184A1 (en) * | 2003-06-27 | 2004-12-29 | McNEIL-PPC, INC. | Soft tablet containing high molecular weight cellulosics |
US20070048373A1 (en) * | 2005-08-30 | 2007-03-01 | Cima Labs Inc. | Dried milled granulate and methods |
Non-Patent Citations (1)
Title |
---|
KERRYN SIMPSON ET AL.: "Fexofenadine:A Review of its Use in the Management of Seasonal Allergic Rhinitis and Chronic Idiopathic Urticaria", 《GRUGS》, vol. 59, no. 2, 29 February 2000 (2000-02-29), pages 301 - 321 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113197867A (zh) * | 2021-05-07 | 2021-08-03 | 济川(上海)医学科技有限公司 | 一种非索非那定掩味颗粒,包含其的掩味组合物和掩味制剂,以及制备方法和用途 |
CN114343230A (zh) * | 2022-02-10 | 2022-04-15 | 湖北中烟工业有限责任公司 | 一种薄片添加剂、其制备方法及含有该薄片添加剂的烟草薄片 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102958515A (zh) | 非索非那定微胶囊及含有非索非那定微胶囊的组合物 | |
JP6932746B2 (ja) | エンザルタミドの製剤 | |
JP5632367B2 (ja) | Bibw2992を含有する固形医薬製剤 | |
KR101141508B1 (ko) | 판토프라졸 복합 미립자 제형 | |
KR20010082251A (ko) | 서방성 입자 | |
CZ297251B6 (cs) | Fenofibrátový prostredek s okamzitým uvolnováním,zpusob prípravy farmaceutického prostredku a suspenze fenofibrátu v mikronizované forme | |
HU196304B (en) | Process for production of granulates of medical active substances with delaying effect | |
WO2005097070A1 (ja) | 安定性の向上した固形製剤およびその製造方法 | |
US20150238616A1 (en) | Solid preparation comprising enteric solid dispersion | |
CN105188676A (zh) | 包括葡糖激酶活化剂的固体组合物及其制备和使用方法 | |
WO2017093890A1 (en) | Clobazam tablet formulation and process for its preparation | |
CA3160834A1 (en) | Amorphous pharmaceutical compositions of abiraterone acetate | |
US20200046695A1 (en) | Oral pharmaceutical composition of lurasidone and preparation thereof | |
JP6211044B2 (ja) | 薬物含有中空粒子 | |
JPWO2014030656A1 (ja) | 薬物含有中空粒子 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB02 | Change of applicant information |
Address after: Dublin, Ireland Applicant after: APTALIS PHARMA LTD. Address before: Wicklow Applicant before: Aptalis Pharma Ltd. |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20161025 Address after: Milan Italy Applicant after: ADARE PHARMACEUTICALS S.R.L. Address before: Dublin, Ireland Applicant before: APTALIS PHARMA LTD. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130306 |